Cambridge, United States
Research view
Bipolar disorder: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- GLP-1 0
- BDNF 0
- NMDA 1
- SGLT2 1
- PI3K 0
- AQP4 0
- PCSK9 0
- PPAR 0
- TNF 0
- AKT 0
- BRD4 0
- G6PD 0
- IGF1R 0
- IL-1 0
- IL-17 0
- IL-6 0
- MAPT 0
- NLRP3 0
- NRF2 0
- SIRT1 0
- TFEB 0
EU-13 is a filter, not a ranking: it only narrows the list.
Toronto, Canada
London, United Kingdom
Madrid, Spain
Barcelona, Spain
Stockholm, Sweden
Copenhagen, Denmark
Barcelona, Spain
Barcelona, Spain
Madrid, Spain
Paris, France
Rochester, United States
Oxford, United Kingdom
Boston, United States
Pittsburgh, United States
Baltimore, United States
Halifax, Canada
Melbourne, Australia
Oslo, Norway
Aarhus, Denmark
Toronto, Canada
New York, United States
Vancouver, Canada
New Haven, United States
24 of 1,446 institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
“The site in Israel stopped recruitment due to logistic reasons. Other sites are recruiting for 2023-506602-39-00, 2023-506605-19-00, 2023-506617-21-00.”Registry text, quoted unchanged. Source
Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
“Administrative”Registry text, quoted unchanged. Source
Withdrawn
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
“Study did not receive funding and was never carried out.”Registry text, quoted unchanged. Source
Terminated
Brain Circuitry Analysis in Bipolar Disorder
“The original funding for this study ended and we were not able to secure new funding to continue”Registry text, quoted unchanged. Source
Suspended
IM Ketamine vs Midazolam for Suicidal ER Patients
“The U.S. Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP) issued an FWA restriction on NYSPI research that also included a pause of human subjects research as of June 23, 2023.”Registry text, quoted unchanged. Source
Withdrawn
Dopamine D3 Receptor Occupancy in Bipolar Depression
“Funding decision”Registry text, quoted unchanged. Source
Terminated
Alexithymia Intervention for Suicide
“Staff turnover and trouble with recruitment, staffing, and paying invoices.”Registry text, quoted unchanged. Source
Withdrawn
Lifestyle MIND- Feasibility of Wait-list Control
“No funding obtained”Registry text, quoted unchanged. Source
Suspended
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
“Difficulties recruiting”Registry text, quoted unchanged. Source
Withdrawn
“Study did not start - due to funding issues prior to IRB approval”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 6
- Mendelian Randomization Analysis 52
- CRISPR-Cas Systems 2
- Gene Expression Profiling 22
- Sequence Analysis, RNA 1
- Whole Genome Sequencing 2
- Exome Sequencing 3
- Proteomics 17
- Metabolomics 8
- Mass Spectrometry 3
- Immunohistochemistry 1
- Positron-Emission Tomography 13
- Magnetic Resonance Imaging 190
- Machine Learning 59
- Deep Learning 9
- Cohort Studies 96
- Genome-Wide Association Study 107
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.